These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 7840829

  • 1. [p53: an important or most overvalued tumor gene?].
    Schlegel U.
    Laryngorhinootologie; 1994 Dec; 73(12):651-3. PubMed ID: 7840829
    [Abstract] [Full Text] [Related]

  • 2. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S.
    Oncogene; 1997 Aug 14; 15(7):871-4. PubMed ID: 9266974
    [Abstract] [Full Text] [Related]

  • 3. Chromosomal instability and p53 inactivation are required for genesis of glioblastoma but not for colorectal cancer in patients with germline mismatch repair gene mutation.
    Leung SY, Yuen ST, Chan TL, Chan AS, Ho JW, Kwan K, Fan YW, Hung KN, Chung LP, Wyllie AH.
    Oncogene; 2000 Aug 17; 19(35):4079-83. PubMed ID: 10962567
    [Abstract] [Full Text] [Related]

  • 4. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 5. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Oncol Rep; 2004 Jan 01; 11(1):207-11. PubMed ID: 14654927
    [Abstract] [Full Text] [Related]

  • 6. p53 and disease: when the guardian angel fails.
    Royds JA, Iacopetta B.
    Cell Death Differ; 2006 Jun 01; 13(6):1017-26. PubMed ID: 16557268
    [Abstract] [Full Text] [Related]

  • 7. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr 01; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 8. Clonal expansion of p53 mutant cells is associated with brain tumour progression.
    Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B.
    Nature; 1992 Feb 27; 355(6363):846-7. PubMed ID: 1311419
    [Abstract] [Full Text] [Related]

  • 9. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994 Feb 27; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 10. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M, Peraud A, Leroch B, Kreth FW.
    Cancer; 2004 Sep 01; 101(5):1028-35. PubMed ID: 15329912
    [Abstract] [Full Text] [Related]

  • 11. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM.
    J Urol; 2003 Apr 01; 169(4):1219-28. PubMed ID: 12629332
    [Abstract] [Full Text] [Related]

  • 12. Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy.
    Turner BC, Gumbs AA, Carbone CJ, Carter D, Glazer PM, Haffty BG.
    Cancer; 2000 Mar 01; 88(5):1091-8. PubMed ID: 10699900
    [Abstract] [Full Text] [Related]

  • 13. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG, Dobberstein KU, Fittkau M, Bahn H, Holzhausen HJ, Gantchev L, Burkert W.
    Clin Cancer Res; 1995 Jul 01; 1(7):775-81. PubMed ID: 9816045
    [Abstract] [Full Text] [Related]

  • 14. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar 01; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 15. Expression of the p53 protein in a spectrum of astrocytic tumours.
    Ellison DW, Gatter KC, Steart PV, Lane DP, Weller RO.
    J Pathol; 1992 Dec 01; 168(4):383-6. PubMed ID: 1336544
    [Abstract] [Full Text] [Related]

  • 16. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 17. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J, Jensen V, Kyndi M, Offersen BV, Vu P, Børresen-Dale AL, Overgaard J.
    Acta Oncol; 2008 May 15; 47(4):600-7. PubMed ID: 18465328
    [Abstract] [Full Text] [Related]

  • 18. Mutations in the p53 gene occur in diverse human tumour types.
    Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hostetter R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P.
    Nature; 1989 Dec 07; 342(6250):705-8. PubMed ID: 2531845
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT, Chang KJ, Chen JC, Lee CC, Cheng YM, Hsu HC, Chien CT, Wang SM.
    Hepatogastroenterology; 1999 Dec 07; 46(26):883-90. PubMed ID: 10370632
    [Abstract] [Full Text] [Related]

  • 20. Genetically distinct astrocytic and oligodendroglial components in oligoastrocytomas.
    Qu M, Olofsson T, Sigurdardottir S, You C, Kalimo H, Nistér M, Smits A, Ren ZP.
    Acta Neuropathol; 2007 Feb 07; 113(2):129-36. PubMed ID: 17031656
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.